Details for New Drug Application (NDA): 200695
✉ Email this page to a colleague
The generic ingredient in BUPROPION HYDROCHLORIDE is bupropion hydrochloride. There are thirty-eight drug master file entries for this compound. Seventy-five suppliers are listed for this compound. Additional details are available on the bupropion hydrochloride profile page.
Summary for 200695
Tradename: | BUPROPION HYDROCHLORIDE |
Applicant: | Sun Pharm |
Ingredient: | bupropion hydrochloride |
Patents: | 0 |
Formulation / Manufacturing: | see details |
Pharmacology for NDA: 200695
Mechanism of Action | Dopamine Uptake Inhibitors Norepinephrine Uptake Inhibitors |
Physiological Effect | Increased Dopamine Activity Increased Norepinephrine Activity |
Suppliers and Packaging for NDA: 200695
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
BUPROPION HYDROCHLORIDE | bupropion hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 200695 | ANDA | Sun Pharmaceutical Industries, Inc. | 47335-954 | 47335-954-13 | 500 TABLET, EXTENDED RELEASE in 1 BOTTLE (47335-954-13) |
BUPROPION HYDROCHLORIDE | bupropion hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 200695 | ANDA | Sun Pharmaceutical Industries, Inc. | 47335-954 | 47335-954-81 | 90 TABLET, EXTENDED RELEASE in 1 BOTTLE (47335-954-81) |
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET, EXTENDED RELEASE;ORAL | Strength | 150MG | ||||
Approval Date: | Dec 18, 2014 | TE: | RLD: | No |
Complete Access Available with Subscription